May 4, 2020
Authored and Edited by Kathryn R. Judson; Kathleen A. Daley
In CardioNet, LLC v. InfoBionic, Inc., No. 2019-1149 (Fed. Cir. Apr. 17, 2020), the Federal Circuit reversed the district court’s determination that the claims covering a device for monitoring electrical activity in the heart to detect the presence of atrial fibrillation were patent ineligible under 35 U.S.C. § 101. The Court explained that the claims were not directed to an abstract idea, but instead a patent-eligible improvement to cardiac monitoring technology. The Court cautioned against oversimplifying the claims and clarified that the Alice step one inquiry can be resolved at the Rule 12(b)(6) stage without looking outside the intrinsic evidence. Judge Dyk dissented-in-part, arguing that the majority improperly assessed the role of extrinsic evidence in the patent-eligibility analysis. Further discussion of the decision can be found on Finnegan’s Federal Circuit IP Blog.
United States Court of Appeals for the Federal Circuit (CAFC), patent-eligible, claim construction, Written description (35 USC § 112)
Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Hybrid Conference
2024 California Intellectual Property Law Institute
October 21-22,2024
San Francisco
Conference
2024 Licensing Executives Society USA – Canada Annual Meeting
October 20-23, 2024
New Orleans
Hybrid Conference
2024 Patent Law Institute: Critical Issues & Best Practices
September 30 - October 1, 2024
New York
Hybrid Conference
2024 New York Intellectual Property Law Institute
September 30 - October 1, 2024
New York
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.